University of Kansas Cancer Center, Clinical Research Center

Fairway, Kansas 66208

0 studies enrolling now · 6 studies all time

What they study most

Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Advanced Solid Tumors, Bladder Cancer, Breast Cancer, Multiple Myeloma, Pancreas Cancer, Pancreatic Cancer, Triple-Negative Breast Cancer

Studies at this site

• Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) — Running, not enrolling
• Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer — Running, not enrolling
• Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial — Status unconfirmed
• A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer — Status unconfirmed
• Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia — Completed
• Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment — Completed